Annual Accounts Payable:
$45.66M+$8.97M(+24.46%)Summary
- As of today, ANIP annual accounts payable is $45.66 million, with the most recent change of +$8.97 million (+24.46%) on December 31, 2024.
- During the last 3 years, ANIP annual accounts payable has risen by +$22.69 million (+98.79%).
- ANIP annual accounts payable is now at all-time high.
Performance
ANIP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$69.80M+$15.23M(+27.90%)Summary
- As of today, ANIP quarterly accounts payable is $69.80 million, with the most recent change of +$15.23 million (+27.90%) on September 30, 2025.
- Over the past year, ANIP quarterly accounts payable has increased by +$8.90 million (+14.62%).
- ANIP quarterly accounts payable is now at all-time high.
Performance
ANIP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ANIP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +24.5% | +14.6% |
| 3Y3 Years | +98.8% | +267.5% |
| 5Y5 Years | +212.6% | +418.5% |
ANIP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +98.8% | at high | +267.5% |
| 5Y | 5-Year | at high | +305.4% | at high | +519.8% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
ANIP Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $69.80M(+27.9%) |
| Jun 2025 | - | $54.57M(+2.8%) |
| Mar 2025 | - | $53.06M(+16.2%) |
| Dec 2024 | $45.66M(+24.5%) | $45.66M(-25.0%) |
| Sep 2024 | - | $60.89M(+25.1%) |
| Jun 2024 | - | $48.68M(-1.5%) |
| Mar 2024 | - | $49.43M(+34.7%) |
| Dec 2023 | $36.68M(+25.2%) | $36.68M(+7.6%) |
| Sep 2023 | - | $34.08M(+19.5%) |
| Jun 2023 | - | $28.50M(-12.8%) |
| Mar 2023 | - | $32.69M(+11.5%) |
| Dec 2022 | $29.30M(+27.6%) | $29.30M(+54.3%) |
| Sep 2022 | - | $18.99M(-31.3%) |
| Jun 2022 | - | $27.64M(+25.3%) |
| Mar 2022 | - | $22.06M(-4.0%) |
| Dec 2021 | $22.97M(+104.0%) | $22.97M(+99.5%) |
| Sep 2021 | - | $11.51M(-11.3%) |
| Jun 2021 | - | $12.98M(-5.8%) |
| Mar 2021 | - | $13.77M(+22.3%) |
| Dec 2020 | $11.26M(-22.9%) | $11.26M(-16.3%) |
| Sep 2020 | - | $13.46M(-5.3%) |
| Jun 2020 | - | $14.21M(+13.8%) |
| Mar 2020 | - | $12.48M(-14.5%) |
| Dec 2019 | $14.61M(+64.4%) | $14.61M(+33.4%) |
| Sep 2019 | - | $10.95M(+11.7%) |
| Jun 2019 | - | $9.81M(-6.7%) |
| Mar 2019 | - | $10.52M(+18.4%) |
| Dec 2018 | $8.88M(+144.7%) | $8.88M(+22.4%) |
| Sep 2018 | - | $7.26M(-8.7%) |
| Jun 2018 | - | $7.95M(+62.7%) |
| Mar 2018 | - | $4.89M(+34.6%) |
| Dec 2017 | $3.63M(+7.1%) | $3.63M(-37.6%) |
| Sep 2017 | - | $5.82M(+84.6%) |
| Jun 2017 | - | $3.15M(-34.1%) |
| Mar 2017 | - | $4.79M(+41.2%) |
| Dec 2016 | $3.39M(+64.0%) | $3.39M(-28.4%) |
| Sep 2016 | - | $4.73M(-4.7%) |
| Jun 2016 | - | $4.96M(+63.2%) |
| Mar 2016 | - | $3.04M(+47.1%) |
| Dec 2015 | $2.07M(-22.2%) | $2.07M(-21.5%) |
| Sep 2015 | - | $2.63M(+98.7%) |
| Jun 2015 | - | $1.32M(-42.1%) |
| Mar 2015 | - | $2.29M(-13.8%) |
| Dec 2014 | $2.65M(+85.7%) | $2.65M(+28.9%) |
| Sep 2014 | - | $2.06M(+18.9%) |
| Jun 2014 | - | $1.73M(-34.9%) |
| Mar 2014 | - | $2.66M(+86.1%) |
| Dec 2013 | $1.43M | $1.43M(-31.5%) |
| Sep 2013 | - | $2.09M(+27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $1.63M(+894.4%) |
| Mar 2013 | - | $164.40K(-85.4%) |
| Dec 2012 | $1.13M(-64.2%) | $1.13M(-43.7%) |
| Sep 2012 | - | $2.00M(-47.7%) |
| Jun 2012 | - | $3.84M(+16.9%) |
| Mar 2012 | - | $3.28M(+4.2%) |
| Dec 2011 | $3.15M(-35.2%) | $3.15M(-47.9%) |
| Sep 2011 | - | $6.04M(-4.8%) |
| Jun 2011 | - | $6.35M(-25.3%) |
| Mar 2011 | - | $8.50M(+74.8%) |
| Dec 2010 | $4.86M(+99.3%) | $4.86M(+7.5%) |
| Sep 2010 | - | $4.52M(-4.2%) |
| Jun 2010 | - | $4.72M(+17.9%) |
| Mar 2010 | - | $4.00M(+64.0%) |
| Dec 2009 | $2.44M(-23.3%) | $2.44M(-30.9%) |
| Sep 2009 | - | $3.53M(+38.4%) |
| Jun 2009 | - | $2.55M(+5.0%) |
| Mar 2009 | - | $2.43M(-23.7%) |
| Dec 2008 | $3.18M(+347.8%) | $3.18M(-7.0%) |
| Sep 2008 | - | $3.42M(+30.5%) |
| Jun 2008 | - | $2.62M(+13.8%) |
| Mar 2008 | - | $2.30M(+223.8%) |
| Dec 2007 | $710.60K(+14.3%) | $710.60K(+27.0%) |
| Sep 2007 | - | $559.40K(-37.1%) |
| Jun 2007 | - | $888.80K(+38.1%) |
| Mar 2007 | - | $643.80K(+3.5%) |
| Dec 2006 | $621.80K(-45.4%) | $621.80K(+95.4%) |
| Sep 2006 | - | $318.30K(-52.5%) |
| Jun 2006 | - | $669.70K(-51.5%) |
| Mar 2006 | - | $1.38M(+21.1%) |
| Dec 2005 | $1.14M(-2.5%) | $1.14M(+119.8%) |
| Sep 2005 | - | $518.50K(-33.7%) |
| Jun 2005 | - | $782.50K(-25.7%) |
| Mar 2005 | - | $1.05M(-9.9%) |
| Dec 2004 | $1.17M(+389.7%) | $1.17M(+36.5%) |
| Sep 2004 | - | $856.10K(+40.7%) |
| Jun 2004 | - | $608.30K(+61.9%) |
| Mar 2004 | - | $375.80K(+57.2%) |
| Dec 2003 | $238.70K(-49.3%) | $239.00K(-12.1%) |
| Sep 2003 | - | $272.00K(-43.2%) |
| Jun 2003 | - | $479.00K(+93.1%) |
| Mar 2003 | - | $248.00K(-47.3%) |
| Dec 2002 | $470.90K(+419.2%) | $471.00K(+447.7%) |
| Dec 2001 | $90.70K(+102.9%) | $86.00K(+91.1%) |
| Dec 2000 | $44.70K(-41.3%) | $45.00K(-35.7%) |
| Dec 1999 | $76.10K(+10.6%) | - |
| Dec 1999 | - | $70.00K(-51.5%) |
| Sep 1999 | - | $144.30K |
| Dec 1998 | $68.80K | - |
FAQ
- What is ANI Pharmaceuticals, Inc. annual accounts payable?
- What is the all-time high annual accounts payable for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. annual accounts payable year-on-year change?
- What is ANI Pharmaceuticals, Inc. quarterly accounts payable?
- What is the all-time high quarterly accounts payable for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
What is ANI Pharmaceuticals, Inc. annual accounts payable?
The current annual accounts payable of ANIP is $45.66M
What is the all-time high annual accounts payable for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high annual accounts payable is $45.66M
What is ANI Pharmaceuticals, Inc. annual accounts payable year-on-year change?
Over the past year, ANIP annual accounts payable has changed by +$8.97M (+24.46%)
What is ANI Pharmaceuticals, Inc. quarterly accounts payable?
The current quarterly accounts payable of ANIP is $69.80M
What is the all-time high quarterly accounts payable for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high quarterly accounts payable is $69.80M
What is ANI Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
Over the past year, ANIP quarterly accounts payable has changed by +$8.90M (+14.62%)